Low AMH but a Normal Follicle Count: What Should Guide IVF?

A low anti-Müllerian hormone (AMH) result alongside a reassuring antral follicle count (AFC) can look like two tests disagreeing about the same future. In reality, neither value predicts a personal pregnancy outcome on its own. AMH is a blood marker related to the pool of developing follicles; AFC counts small follicles visible on ultrasound at a particular examination. Age, laboratory method, scan quality and prior ovarian response still matter.

First confirm the units, reference range, assay and date of the AMH result. Review whether the ultrasound counted follicles on both ovaries and whether a cyst, previous surgery or technical limitation affected visibility. Ovarian reserve tests are mainly useful in anticipating response to stimulation rather than proving someone can or cannot conceive naturally. A normal AFC does not erase a low AMH; a low AMH does not make IVF inevitable.

If cycles are regular and other factors are favourable, the clinician may discuss timed attempts or a limited IUI approach. Tubal disease, significant male-factor infertility, age or longer infertility duration can change that choice. In IVF, reserve tests help individualise starting stimulation, monitoring and counselling about the possibility of fewer eggs than hoped. Ask how the team will define an adequate response and whether a protocol change is reasonable.

Convenience should be clinically conditional. HomeIVF seeks to make doctor-led fertility treatment less disruptive by coordinating some conversations and eligible monitoring tasks beyond the main clinic, if safe local options exist. Ask the team to identify the laboratory, escalation route and person interpreting each result. An informal promise of home care without those details is not an adequate clinical plan.

Even a well-coordinated home-supported pathway retains essential facility care. A transvaginal ultrasound, when indicated, assesses anatomy and follicle development in ways a blood test cannot. IUI needs appropriate preparation and clinical equipment. Egg retrieval requires a clinical procedure area and, when prescribed, anaesthesia. Embryology, embryo biopsy, cryostorage and embryo transfer require specialised teams and controlled facilities. These boundaries protect the patient and the reproductive material.

Bring both original test reports rather than photographs of a value alone. Record ovarian surgery, endometriosis history, chemotherapy exposure and previous cycles. If an older test used different units, the clinician should reconcile them rather than averaging numbers. Time-sensitive decisions should be based on the whole fertility assessment, not on repeatedly buying AMH tests to seek a more comforting result.

For a useful clinician review, gather original reports with dates, units and laboratory names, not only highlighted abnormal values. Include prescribed medicines and doses, relevant imaging, previous treatment summaries and a short timeline of symptoms or unsuccessful attempts. If another clinic performed a procedure, request its report rather than repeating it by default. Good documentation can reduce unnecessary appointments while making it easier to identify which tests really need repeating.

A reliable treatment budget separates assessment from therapy. Ask for a written estimate covering consultations, imaging, ordered blood or semen tests, medicines, nursing support when relevant, procedure and anaesthesia fees, embryology, freezing, storage and follow-up. Not every line applies to every patient. Ask which fees are refundable if a cycle changes, whether an add-on is optional and what evidence supports it. Travel costs should also be planned for required facility appointments.

Avoid internet “egg-count calculators” that claim to predict the number of future children. Neither reserve value measures egg genetic quality reliably, and no supplement is known to reverse ovarian ageing. If a facility scan is advised, remote interpretation alone is insufficient. Home collection of some blood tests may be possible where properly arranged, but a count of visible follicles still requires ultrasound.

At the end of the discussion, request a brief written summary of the working diagnosis, why the next test or treatment was selected, which alternatives remain reasonable, and the date or result that should trigger review. Also ask what symptoms need same-day advice rather than the next planned call. There is value in knowing what would change the plan, including new scans, semen findings or medication side effects. Uncertainty should be explained, not hidden behind a package promise.

Seek urgent direct medical assessment for severe pain, breathing problems, fainting, significant bleeding or rapidly worsening symptoms. An online result or scheduled teleconsultation cannot rule out complications. Never change a prescribed fertility medicine solely because of this article.

A HomeIVF discussion can start with your existing records and a specific decision you want help making. Where available and suitable, the team can explain which follow-ups may be remote and which require an equipped facility. It should also clarify service limitations before you book travel or medicines. Use this guide as preparation for informed clinical advice, not as an instruction to begin or change treatment on your own.